Related Experiment Video
Updated: Jul 16, 2026

New Features in Visual Dynamics 3.0
Published on: August 9, 2024
Mdm2 widens its repertoire
Amanda S Coutts1, Nicholas B La Thangue
1Laboratory of Cancer Biology, Division of Medical Sciences, University of Oxford, Oxford, UK.
Abstract:
The p53 tumor suppressor protein is a DNA damage responsive transcription factor that affects diverse cellular processes which include transcription, DNA synthesis and repair, cell cycle arrest, senescence and apoptosis. The Mdm2 oncoprotein is a primary regulator of p53, mediating p53 control via ubiquitin-dependent proteasomal degradation. During DNA damage, the interaction between p53 and Mdm2 is reduced, which allows p53 levels to accumulate. p53 activity is tightly controlled and regulated at a multiplicity of levels, and the importance of co-factors that influence p53 activity is becoming increasingly evident. Recent studies have highlighted the role of Mdm2 in the control of p53 co-factors. Thus, Mdm2 targets JMY, a p53 co-factor, for ubiquitin-dependent Mdm2 targets JMY, a p53 co-factor, for ubiquitin-dependent proteasomal degradation and in doing so overcomes the ability of JMY to augment the p53 response. These results define a new functional relationship between control of p53 activity and Mdm2, and suggest that transcription co-factors which facilitate the p53 response are important targets through which Mdm2 mediates its oncogenic activity.
Insights
The Mdm2 oncoprotein degrades the p53 co-factor JMY, hindering the tumor suppressor
Area of Science:
- Molecular Biology
- Oncology
- Cellular Biology
Background:
- p53 is a tumor suppressor protein crucial for DNA repair and apoptosis.
- Mdm2 is an oncoprotein that regulates p53 stability through proteasomal degradation.
- p53 activity is tightly controlled, with co-factors playing an increasingly recognized role.
Purpose of the Study:
- To investigate the role of Mdm2 in regulating p53 co-factors.
- To elucidate the mechanism by which Mdm2 influences the p53 response.
Main Methods:
- Ubiquitin-dependent proteasomal degradation assays.
- Analysis of the interaction between Mdm2, p53, and JMY.
- Assessment of JMY's effect on p53 activity.
Main Results:
- Mdm2 targets JMY, a p53 co-factor, for degradation.
- Mdm2 antagonizes JMY's ability to enhance the p53 response.
- Reduced p53-Mdm2 interaction upon DNA damage allows p53 accumulation.
Conclusions:
- Mdm2 utilizes JMY degradation as a mechanism to suppress the p53 tumor suppressor activity.
- Transcription co-factors are key targets for Mdm2's oncogenic functions.
- Understanding Mdm2-JMY interaction offers new therapeutic strategies for cancer.
Related Concept Videos
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Midrange
Simply put, the midrange is half of the data set’s range. Similar to the mean, the midrange is sensitive to the extreme values and hence the prospective outliers. However, unlike the mean, the midrange is not sensitive to all the values of the data set that lie in the middle. Thus, it is prone to outliers and...
¹³C NMR: Distortionless Enhancement by Polarization Transfer (DEPT)
Cardiomyopathy II: Dilated Cardiomyopathy

